5 min read

πŸ›ŽοΈ DeepSeek Proves Ilya Right

Plus: Your Tumor Picks the Cure, The Robots Have Never Had a Job

Good Morning, AI Enthusiasts!

The industry has spent billions making models larger. The interesting work now is learning which parts of largeness were doing the job.


LLM

DeepSeek Proves Ilya Right

πŸ‘€ What's happening: Ilya Sutskever left OpenAI to found SSI, then told Dwarkesh Patel the industry had wandered into the wrong era. Scaling was over. Data is finite. Pre-training will run out. That was in November. This week DeepSeek shipped the receipt: a model a third the parameters of its own flagship, beating it on the work agents actually do.

🌍 How this hits reality: V4.1 Flash carries 552 billion parameters and wakes only 8 to 16 billion per token. V4-Pro carries 1.6 trillion and wakes 49 billion. On DeepSeek's own coding tests the lean model won, 74.2 to 62.7, and on September 14 every V4-Pro request reroutes to it. Ilya's point was never that models should get smaller. It was that the returns moved.

πŸ›ŽοΈ Key takeaway: For five years the moat was cluster size. Ilya called the shift. DeepSeek shipped the evidence.


NEW TECH

Your Tumor Picks the Cure

πŸ‘€ What's happening: Nature just published an AI model that tells doctors which cancer drug will work on a patient, before any dose. It targets triple-negative breast cancer, 15 to 20 percent of cases, where no targeted drug works, so everyone gets the same chemotherapy. Trained on 38 million protein measurements at Westlake University, it hit 88 percent accuracy on drugs it had never seen and matched real outcomes in 501 patients. Nature calls it the first virtual cell model to reach the clinic.

🌍 How this hits reality: Cancer care has been a bet placed on the patient: treat the body, then learn later who it helped. This model moves more of that test off the person and onto the tumor, reading its proteins across time and ranking the drugs most likely to fit. The drug stops being pushed at a diagnosis and starts being pulled by the patient's own sample. That reversal, not the accuracy score, is the shock.

πŸ›ŽοΈ Key takeaway: For decades the body was the experiment and survival was the data. Now the tumor starts running the trial, and the patient finally gets to be only the patient.


ROBOTICS

The Robots Have Never Had a Job

πŸ‘€ What's happening: A senior Hyundai executive told Reuters that Boston Dynamics, the group's humanoid unit and the world's most famous robot company, is unlikely to go public next year. Its Atlas robots are not deployed at scale and it is not profitable. It lost 393 million dollars in 2025, near 1.26 billion since 2021. Analysts still value it at up to 74 billion dollars. Hyundai's stock doubled on an Atlas demo in January, then gave most of it back.

🌍 How this hits reality: When the industry's icon admits this, it admits the whole field. Years of stunning video, not one robot paid to work. Boston Dynamics just told us robotics is still a demo. Which makes the already-listed ones like Unitree worth a second look. Public on what? A prototype and a "promise". The ticker arrived long before the product.

πŸ›ŽοΈ Key takeaway: Robots can dance, sprint, and take a company public. Not one can clock in. The show is the business.


SAFETY

Nobody Wants Anthropic to Guard the Granary

πŸ‘€ What's happening: The Information reported that Nvidia, Palantir, and defense contractor Booz Allen Hamilton are fencing off Anthropic's flagship models. Nvidia shifted proprietary supply-chain work to its own Nemotron. Palantir demands an irrevocable zero-data-retention pledge or it won't ship the models to customers. Booz Allen banned them from client cybersecurity work. The trigger: June 9, when Fable 5 shipped with mandatory 30-day retention across all Mythos-tier models, overriding signed ZDR deals with no opt-out.

🌍 How this hits reality: Pure hubris. Anthropic crowned itself the industry's safety steward, the one party fit to hold every log. It is also the party with the most to gain from reading them. Data is a company's lifeblood, not a document to be filed. It mistook its own hunger for the industry's protection. Its biggest clients didn't argue the fine print. They just took their secrets somewhere it cannot follow.

πŸ›ŽοΈ Key takeaway: Anthropic crowned itself the granary's guard while licking its own chops. A rat's appetite does not become oversight just because the rat says so.


DAILY TL;DR

  • Cloudflare began blocking AI training and agent crawlers by default on ad-supported pages, while keeping search crawlers allowed.
  • Perplexity is letting GPT-6 Astra edit production code, monitor live systems, and draft communications with fewer human check-ins.
  • Cognition released SWE-2, its coding model that claims frontier-level agent performance at lower inference cost.
  • Nvidia reportedly raised AI server prices by more than 15% as high-bandwidth memory supply tightened.
  • Y Combinator CEO Garry Tan argued U.S. open-weight labs should be allowed to distill frontier models, not just compete against them.
  • Claude launched a financial-advisor package connecting portfolio, CRM, custodial, planning, and compliance workflows.
  • China said it will lead a BRICS AI open-source community covering model development, cloud infrastructure, and technical training.
  • Moonshot AI is targeting $2 billion in annualized revenue by year-end on adoption of its open-weight Kimi K3 model.

READ MORE

Let the Future Come to Your Inbox

Stay ahead without drowning in information. We turn the most important signals across AI, tech, marketing, and future products into 5-minute reads you can actually finish.


TOGETHER WITH US

AI Secret Media Group is the world’s #1 AI & Tech Newsletter Group, reaching over 2 million leaders across the global innovation ecosystem, from OpenAI, Anthropic, Google, and Microsoft to top AI labs, VCs, and fast-growing startups.

We've helped promote over 500 Tech Brands. Will yours be the next?

Email our co-founder Mark directly at mark@aisecret.us if the button fails.